Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 11:03AM ET
95.53
Dollar change
+0.91
Percentage change
0.96
%
IndexS&P 500 P/E30.26 EPS (ttm)3.16 Insider Own0.10% Shs Outstand821.41M Perf Week1.74%
Market Cap78.38B Forward P/E24.90 EPS next Y3.84 Insider Trans-32.94% Shs Float819.58M Perf Month1.06%
Income2.61B PEG3.59 EPS next Q0.87 Inst Own86.60% Short Float0.91% Perf Quarter8.23%
Sales19.75B P/S3.97 EPS this Y9.02% Inst Trans-0.61% Short Ratio1.81 Perf Half Y25.25%
Book/sh0.28 P/B340.77 EPS next Y8.97% ROA15.95% Short Interest7.43M Perf Year24.39%
Cash/sh1.60 P/C59.83 EPS next 5Y8.44% ROE2331.25% 52W Range67.62 - 95.59 Perf YTD19.85%
Dividend Est.2.01 (2.11%) P/FCF25.93 EPS past 5Y0.18% ROI31.15% 52W High-0.06% Beta0.38
Dividend TTM1.94 (2.03%) Quick Ratio0.70 Sales past 5Y4.62% Gross Margin59.00% 52W Low41.28% ATR (14)1.15
Dividend Ex-DateJul 19, 2024 Current Ratio1.06 EPS Y/Y TTM65.39% Oper. Margin22.28% RSI (14)63.98 Volatility1.16% 1.15%
Employees34000 Debt/Eq37.78 Sales Y/Y TTM7.71% Profit Margin13.22% Recom1.83 Target Price98.52
Option/ShortYes / Yes LT Debt/Eq35.44 EPS Q/Q85.18% Payout68.86% Rel Volume0.50 Prev Close94.62
Sales Surprise2.12% EPS Surprise5.81% Sales Q/Q6.18% EarningsApr 26 BMO Avg Volume4.11M Price95.53
SMA202.12% SMA504.30% SMA20016.21% Trades Volume573,455 Change0.96%
Date Action Analyst Rating Change Price Target Change
Mar-01-24Resumed Goldman Buy $93
Jan-29-24Upgrade Raymond James Mkt Perform → Outperform
Dec-15-23Upgrade BofA Securities Neutral → Buy $90
Nov-13-23Initiated Jefferies Buy $87
Oct-16-23Upgrade Stifel Hold → Buy $85 → $81
Sep-22-23Initiated HSBC Securities Buy $84
Feb-17-23Initiated Citigroup Buy $84
Jan-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $82
Nov-22-22Initiated Wolfe Research Peer Perform
Oct-13-22Upgrade JP Morgan Neutral → Overweight $79
Jun-14-24 10:42AM
Jun-13-24 04:35PM
01:19PM
11:06AM
Jun-12-24 12:01PM
10:47AM Loading…
10:47AM
Jun-11-24 11:06AM
Jun-10-24 03:51PM
10:27AM
08:00AM
Jun-07-24 01:40PM
09:28AM
Jun-06-24 10:37AM
09:50AM
Jun-05-24 12:56PM
10:31AM Loading…
10:31AM
Jun-04-24 10:20AM
Jun-03-24 12:45PM
11:11AM
09:30AM
06:00AM
May-31-24 04:56PM
12:21PM
May-30-24 10:48AM
May-29-24 11:35AM
May-28-24 10:28AM
04:08AM
May-26-24 05:13PM
May-24-24 11:19AM
May-23-24 11:35AM
12:19PM Loading…
May-22-24 12:19PM
11:45AM
10:00AM
07:00AM
May-21-24 11:46AM
09:35AM
May-20-24 10:27AM
May-17-24 11:41AM
May-16-24 04:17PM
12:45PM
May-14-24 02:11PM
06:21AM
May-13-24 06:46AM
May-10-24 04:25PM
May-09-24 04:47PM
03:53PM
05:44AM
May-08-24 02:17PM
12:15PM
12:28AM
May-07-24 02:50PM
May-06-24 11:45AM
10:51AM
07:44AM
May-03-24 04:07PM
11:02AM
09:40AM
May-01-24 01:41PM
12:09PM
Apr-30-24 12:45PM
09:50AM
08:29AM
08:10AM
06:10AM
Apr-29-24 01:10PM
12:28PM
09:39AM
09:35AM
09:24AM
09:15AM
08:25AM
08:25AM
07:57AM
07:16AM
06:54AM
06:46AM
Apr-28-24 06:54PM
06:49PM
Apr-27-24 01:01AM
Apr-26-24 10:39PM
03:00PM
11:53AM
11:46AM
11:08AM
10:33AM
09:32AM
09:30AM
07:42AM
07:25AM
07:04AM
07:02AM
07:00AM
06:55AM
06:00AM
Apr-25-24 03:00AM
Apr-24-24 03:02AM
Apr-23-24 02:32PM
12:25PM
09:15AM
07:30AM
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daniels JenniferCLO and SecretaryMay 14 '24Option Exercise72.2922,2501,608,45381,948May 16 04:14 PM
Daniels JenniferCLO and SecretaryMay 14 '24Sale94.1522,2502,094,94059,698May 16 04:14 PM
Massey SallyChief Human Resources OfficerMay 09 '24Option Exercise72.2912,226883,81826,150May 10 04:17 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsMay 09 '24Option Exercise72.2912,000867,48017,118May 10 04:16 PM
Massey SallyChief Human Resources OfficerMay 09 '24Sale94.0612,2261,149,92613,924May 10 04:17 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsMay 09 '24Sale94.1512,0001,129,8545,118May 10 04:16 PM
Kooyman John WChief of StaffMay 07 '24Sale93.473,497326,8823,181May 09 04:07 PM
Massey SallyChief Human Resources OfficerMay 01 '24Option Exercise72.296,115442,05320,039May 03 04:04 PM
BILBREY JOHN PDirectorMay 01 '24Option Exercise62.046,329392,65136,565May 03 04:04 PM
BILBREY JOHN PDirectorMay 01 '24Sale91.596,329579,69630,236May 03 04:04 PM
Massey SallyChief Human Resources OfficerMay 01 '24Sale91.926,115562,09113,924May 03 04:04 PM
Wallace Noel R.Chairman, President & CEOFeb 20 '24Option Exercise68.1655,4863,781,926356,829Feb 20 05:05 PM
Wallace Noel R.Chairman, President & CEOFeb 20 '24Sale84.2269,9485,890,887286,881Feb 20 05:05 PM
Daniels JenniferCLO and SecretaryFeb 20 '24Sale84.673,538299,57859,698Feb 20 05:05 PM
Parameswaran PrabhaGrp Pres, Growth & StrategyFeb 16 '24Option Exercise68.1656,8363,873,94275,517Feb 20 04:22 PM
Parameswaran PrabhaGrp Pres, Growth & StrategyFeb 16 '24Sale84.0256,8364,775,37818,681Feb 20 04:22 PM
Wallace Noel R.Chairman, President & CEOFeb 16 '24Sale84.0629,7722,502,664301,343Feb 20 05:05 PM
Daniels JenniferCLO and SecretaryFeb 16 '24Sale83.965,790486,10863,236Feb 20 05:05 PM
Edwards LisaDirectorFeb 13 '24Option Exercise69.382,078144,17211,805Feb 15 04:09 PM
Wallace Noel R.Chairman, President & CEOFeb 12 '24Option Exercise68.1650,0003,408,000324,179Feb 14 04:11 PM
Wallace Noel R.Chairman, President & CEOFeb 12 '24Sale83.1550,0004,157,280274,179Feb 14 04:11 PM
Kooyman John WChief of StaffFeb 09 '24Option Exercise68.1621,0231,432,92826,305Feb 13 04:11 PM
Kooyman John WChief of StaffFeb 09 '24Sale83.6021,0231,757,4585,282Feb 13 04:11 PM
Daniels JenniferCLO and SecretaryFeb 01 '24Option Exercise68.1661,6334,200,905119,581Feb 02 04:10 PM
Malcolm GregoryEVP and ControllerFeb 01 '24Option Exercise68.169,821669,39916,973Feb 02 04:09 PM
Daniels JenniferCLO and SecretaryFeb 01 '24Sale83.9361,6335,172,69757,948Feb 02 04:10 PM
Malcolm GregoryEVP and ControllerFeb 01 '24Sale85.358,930762,1848,043Feb 02 04:09 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsJan 31 '24Option Exercise68.1630,4332,074,31342,559Feb 02 04:09 PM
HARRIS C MARTINDirectorJan 31 '24Option Exercise62.042,760171,23022,032Feb 02 04:09 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsJan 31 '24Sale84.4130,4332,568,70612,126Feb 02 04:09 PM
HARRIS C MARTINDirectorJan 31 '24Sale84.502,760233,22019,272Feb 02 04:09 PM
Daniels JenniferCLO and SecretaryNov 30 '23Option Exercise68.163,800259,00861,993Dec 04 04:14 PM
Daniels JenniferCLO and SecretaryNov 30 '23Sale79.013,800300,21958,193Dec 04 04:14 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsNov 28 '23Option Exercise68.1615,0001,022,40027,371Nov 30 04:29 PM
Tsourapas PanagiotisGrp Pres, Eur& Developing MktsNov 28 '23Sale77.8315,0001,167,41012,371Nov 30 04:29 PM
CAHILL JOHN TDirectorNov 03 '23Option Exercise62.046,329392,65131,015Nov 07 04:15 PM
CAHILL JOHN TDirectorNov 03 '23Sale74.926,329474,17024,686Nov 07 04:15 PM
Kooyman John WChief of StaffNov 03 '23Sale75.113,000225,3305,347Nov 07 04:14 PM
NORRINGTON LORRIE MDirectorNov 02 '23Option Exercise62.046,329392,65137,636Nov 06 04:22 PM
NORRINGTON LORRIE MDirectorNov 02 '23Sale74.566,329471,91931,307Nov 06 04:22 PM
Wallace Noel R.Chairman, President & CEOSep 11 '23Option Exercise73.0048,6273,549,771295,596Sep 13 04:04 PM
Daniels JenniferCLO and SecretarySep 11 '23Option Exercise73.0024,7041,803,39277,517Sep 13 04:05 PM
Wallace Noel R.Chairman, President & CEOSep 11 '23Sale73.3748,6273,567,982246,969Sep 13 04:04 PM
Daniels JenniferCLO and SecretarySep 11 '23Sale73.3124,7041,811,01652,813Sep 13 04:05 PM
Malcolm GregoryVice President and ControllerAug 31 '23Option Exercise73.0010,493765,98918,345Sep 01 04:03 PM
Malcolm GregoryVice President and ControllerAug 31 '23Sale73.9010,493775,4577,852Sep 01 04:03 PM
Malcolm GregoryVice President and ControllerAug 30 '23Sale73.851,365100,8057,852Sep 01 04:03 PM
Kooyman John WChief of StaffAug 02 '23Option Exercise73.0021,6771,582,42128,061Aug 04 04:05 PM
Kooyman John WChief of StaffAug 02 '23Sale77.6921,6771,684,0626,384Aug 04 04:05 PM
Last Close
Jun 17 11:03AM ET
17.98
Dollar change
-0.06
Percentage change
-0.31
%
Index- P/E- EPS (ttm)-2.64 Insider Own1.17% Shs Outstand492.85M Perf Week-1.45%
Market Cap8.88B Forward P/E16.82 EPS next Y1.07 Insider Trans0.93% Shs Float488.40M Perf Month5.86%
Income-1302.00M PEG- EPS next Q0.24 Inst Own97.98% Short Float3.38% Perf Quarter13.91%
Sales4.37B P/S2.04 EPS this Y5.76% Inst Trans-3.01% Short Ratio3.91 Perf Half Y30.54%
Book/sh12.26 P/B1.47 EPS next Y13.56% ROA-8.74% Short Interest16.51M Perf Year76.05%
Cash/sh0.70 P/C25.75 EPS next 5Y8.93% ROE-19.24% 52W Range8.52 - 18.80 Perf YTD20.64%
Dividend Est.- P/FCF32.42 EPS past 5Y- ROI-11.05% 52W High-4.39% Beta1.45
Dividend TTM- Quick Ratio1.96 Sales past 5Y9.00% Gross Margin42.75% 52W Low110.97% ATR (14)0.47
Dividend Ex-Date- Current Ratio3.29 EPS Y/Y TTM-5619.91% Oper. Margin5.45% RSI (14)61.85 Volatility2.84% 2.62%
Employees9800 Debt/Eq0.95 Sales Y/Y TTM-1.91% Profit Margin-29.83% Recom2.07 Target Price19.09
Option/ShortYes / Yes LT Debt/Eq0.95 EPS Q/Q-69.14% Payout- Rel Volume0.32 Prev Close18.03
Sales Surprise1.45% EPS Surprise24.09% Sales Q/Q-4.14% EarningsMay 08 BMO Avg Volume4.23M Price17.98
SMA202.01% SMA5013.93% SMA20029.50% Trades Volume376,580 Change-0.31%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Jul-21-22Downgrade Goldman Buy → Sell $32 → $19
Jul-12-22Initiated Piper Sandler Neutral $22
Nov-18-21Initiated Morgan Stanley Overweight $40
Jun-07-24 12:00PM
Jun-06-24 08:00AM
May-28-24 07:30PM
06:27AM
May-24-24 02:39AM
04:03PM Loading…
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM
May-08-24 04:04PM
02:00PM Loading…
02:00PM
12:32PM
09:30AM
09:18AM
07:52AM
07:25AM
06:28AM
May-06-24 09:15AM
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
06:30AM
11:37PM Loading…
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
Feb-07-24 01:25PM
Feb-05-24 07:01AM
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Jan-01-24 09:15AM
Dec-19-23 08:00AM
Dec-14-23 05:08PM
Dec-08-23 09:00AM
Dec-07-23 04:37PM
Nov-27-23 08:00AM
Nov-10-23 05:20PM
Nov-09-23 03:49AM
Nov-08-23 04:03PM
12:21AM
Nov-07-23 01:45PM
09:30AM
07:31AM
07:03AM
06:33AM
Nov-02-23 11:33AM
08:00AM
07:16AM
Nov-01-23 09:00AM
Oct-30-23 04:32PM
Oct-17-23 04:57PM
08:00AM
Oct-09-23 09:55AM
Oct-06-23 12:05PM
08:36AM
Oct-05-23 11:22AM
Oct-04-23 06:30AM
Sep-19-23 06:20AM
04:23AM
Sep-12-23 06:40AM
Sep-07-23 04:15PM
Sep-05-23 05:00PM
Aug-09-23 10:36AM
07:56AM
Aug-08-23 12:16AM
Aug-07-23 02:30PM
12:34PM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM
Last Close
Jun 17 11:03AM ET
41.53
Dollar change
-0.28
Percentage change
-0.68
%
IndexS&P 500 P/E10.99 EPS (ttm)3.78 Insider Own0.38% Shs Outstand229.77M Perf Week-6.03%
Market Cap9.54B Forward P/E9.13 EPS next Y4.55 Insider Trans-0.29% Shs Float228.81M Perf Month-2.34%
Income880.80M PEG1.00 EPS next Q0.89 Inst Own93.40% Short Float2.50% Perf Quarter-11.06%
Sales6.70B P/S1.42 EPS this Y9.44% Inst Trans3.71% Short Ratio1.62 Perf Half Y13.74%
Book/sh12.08 P/B3.44 EPS next Y7.07% ROA8.51% Short Interest5.72M Perf Year-4.41%
Cash/sh32.28 P/C1.29 EPS next 5Y11.00% ROE34.96% 52W Range25.99 - 48.80 Perf YTD12.81%
Dividend Est.1.38 (3.33%) P/FCF7.32 EPS past 5Y23.01% ROI7.52% 52W High-14.91% Beta1.62
Dividend TTM1.40 (3.37%) Quick Ratio5.98 Sales past 5Y3.32% Gross Margin72.49% 52W Low59.77% ATR (14)1.02
Dividend Ex-DateJun 07, 2024 Current Ratio6.59 EPS Y/Y TTM2.54% Oper. Margin21.10% RSI (14)44.28 Volatility2.63% 2.23%
Employees18500 Debt/Eq3.34 Sales Y/Y TTM0.50% Profit Margin13.15% Recom1.79 Target Price49.58
Option/ShortYes / Yes LT Debt/Eq3.22 EPS Q/Q-23.58% Payout30.94% Rel Volume0.36 Prev Close41.81
Sales Surprise-1.11% EPS Surprise18.59% Sales Q/Q-1.80% EarningsMay 09 BMO Avg Volume3.53M Price41.53
SMA20-2.64% SMA500.12% SMA20010.89% Trades Volume346,629 Change-0.68%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Reiterated Telsey Advisory Group Outperform $49 → $54
Feb-29-24Downgrade Jefferies Buy → Hold $50
Feb-05-24Upgrade Evercore ISI In-line → Outperform $30 → $50
Dec-12-23Resumed Morgan Stanley Equal-Weight $38
Nov-07-23Initiated Evercore ISI In-line $30
Sep-13-23Downgrade Redburn Atlantic Overweight → Neutral $33
Aug-01-23Upgrade Barclays Equal Weight → Overweight $47 → $59
May-15-23Upgrade Bernstein Mkt Perform → Outperform $50 → $55
Jan-23-23Downgrade Barclays Overweight → Equal Weight $43
Jan-05-23Downgrade Bernstein Outperform → Mkt Perform
Jun-13-24 09:45AM
Jun-12-24 08:12PM
Jun-10-24 02:45PM
Jun-05-24 11:53AM
Jun-03-24 03:38PM
06:00AM Loading…
06:00AM
May-31-24 09:00AM
08:00AM
May-30-24 02:30PM
May-29-24 06:26PM
08:45AM
May-28-24 09:30AM
May-25-24 05:22PM
May-24-24 07:15AM
07:00AM
12:05AM Loading…
May-23-24 12:05AM
May-21-24 12:01AM
May-20-24 12:07PM
May-16-24 02:15PM
01:11PM
10:44AM
10:44AM
07:01AM
May-13-24 05:48PM
02:30PM
11:05AM
12:01AM
May-10-24 01:38PM
12:31PM
12:02PM
09:02AM Loading…
09:02AM
08:54AM
07:11AM
06:22AM
May-09-24 10:20PM
05:21PM
02:36PM
11:00AM
10:53AM
09:30AM
08:36AM
08:21AM
08:20AM
07:55AM
06:58AM
06:51AM
06:49AM
06:47AM
06:45AM
May-08-24 02:08PM
03:06AM
May-07-24 03:15PM
08:00AM
May-06-24 11:45AM
09:16AM
May-05-24 10:18AM
May-02-24 10:01AM
08:45AM
07:00AM
Apr-30-24 02:37PM
10:54AM
08:45AM
Apr-29-24 12:01AM
Apr-26-24 08:45AM
Apr-25-24 06:45AM
02:00AM
Apr-24-24 01:58PM
Apr-23-24 05:55PM
05:18PM
12:59PM
11:53AM
11:53AM
10:31AM
09:05AM
08:55AM
06:29AM
Apr-22-24 06:21PM
05:46PM
05:38PM
05:29PM
05:12PM
05:10PM
04:59PM
12:02PM
Apr-20-24 07:00AM
Apr-19-24 09:00AM
Apr-17-24 07:47PM
07:44AM
Apr-16-24 05:48AM
Apr-15-24 12:29PM
12:04PM
10:58AM
Apr-12-24 10:45AM
Apr-09-24 04:32PM
Apr-05-24 09:40AM
Apr-04-24 03:33PM
08:00AM
Apr-03-24 06:43PM
01:33PM
11:42AM
Tapestry, Inc. engages in the provision of luxury accessories and lifestyle brands. It operates through the following segments: Coach, Kate Spade, and Stuart Weitzman. The Coach segment consists of global sales of Coach brand products to customers through Coach operated stores, including the internet and concession shop-in-shops, and sales to wholesale customers, and through independent third-party distributors. The Kate Spade segment focuses on Kate Spade New York brand products to customers through Kate Spade operated stores, including the Internet, sales to wholesale customers, through concession shop-in-shops and through independent third-party distributors. The Stuart Weitzman segment includes Stuart Weitzman brand products primarily through Stuart Weitzman operated stores. The company was founded by Dawn Hughes in 1941 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dadlani ManeshVP, Controller and PAOMay 24 '24Sale42.232,500105,57537,173May 29 06:23 PM
Last Close
Jun 17 11:03AM ET
1.75
Dollar change
-0.04
Percentage change
-2.23
%
Index- P/E24.37 EPS (ttm)0.07 Insider Own80.39% Shs Outstand660.73M Perf Week3.86%
Market Cap1.16B Forward P/E10.26 EPS next Y0.17 Insider Trans-0.01% Shs Float129.76M Perf Month6.06%
Income48.37M PEG4.00 EPS next Q0.03 Inst Own18.12% Short Float6.49% Perf Quarter2.64%
Sales443.42M P/S2.61 EPS this Y-10.53% Inst Trans-1.58% Short Ratio4.19 Perf Half Y-32.43%
Book/sh1.29 P/B1.35 EPS next Y19.17% ROA2.78% Short Interest8.43M Perf Year-52.05%
Cash/sh0.77 P/C2.28 EPS next 5Y6.10% ROE5.82% 52W Range1.19 - 4.26 Perf YTD-31.10%
Dividend Est.- P/FCF6.72 EPS past 5Y-0.81% ROI3.22% 52W High-58.97% Beta2.45
Dividend TTM- Quick Ratio9.12 Sales past 5Y46.30% Gross Margin60.15% 52W Low47.06% ATR (14)0.13
Dividend Ex-Date- Current Ratio10.71 EPS Y/Y TTM-76.43% Oper. Margin20.81% RSI (14)53.07 Volatility9.18% 7.33%
Employees233 Debt/Eq0.76 Sales Y/Y TTM-29.82% Profit Margin10.91% Recom3.00 Target Price2.36
Option/ShortYes / Yes LT Debt/Eq0.76 EPS Q/Q-61.89% Payout0.00% Rel Volume0.44 Prev Close1.79
Sales Surprise3.95% EPS Surprise7.53% Sales Q/Q-13.08% EarningsMay 02 BMO Avg Volume2.01M Price1.75
SMA203.29% SMA5011.86% SMA200-9.68% Trades Volume246,376 Change-2.23%
Date Action Analyst Rating Change Price Target Change
Mar-19-24Upgrade Piper Sandler Underweight → Neutral $1.25 → $2
Oct-04-23Upgrade Barclays Underweight → Equal Weight
Aug-25-23Downgrade Piper Sandler Neutral → Underweight $3 → $2
Aug-11-23Downgrade Canaccord Genuity Buy → Hold $5 → $3
Aug-09-23Downgrade Telsey Advisory Group Outperform → Market Perform $6 → $4
Mar-16-23Downgrade TD Cowen Outperform → Market Perform $10 → $4.50
Mar-01-23Downgrade Goldman Buy → Neutral $6
Nov-17-22Initiated Canaccord Genuity Buy $8
Oct-19-22Downgrade Raymond James Strong Buy → Mkt Perform
Oct-19-22Downgrade Morgan Stanley Overweight → Equal-Weight $13 → $6.50
May-24-24 06:55AM
May-06-24 10:52AM
May-03-24 09:30AM
03:34AM
May-02-24 10:53AM
09:52AM Loading…
09:52AM
09:30AM
07:30AM
06:48AM
06:45AM
May-01-24 03:15AM
Apr-25-24 10:02AM
Apr-18-24 07:45AM
Apr-05-24 11:59AM
Apr-04-24 05:20PM
01:57PM Loading…
Mar-25-24 01:57PM
Mar-01-24 09:57AM
01:40AM
Feb-29-24 12:28PM
12:14PM
09:30AM
08:53AM
07:55AM
07:00AM
06:45AM
Feb-28-24 02:02AM
Feb-27-24 06:45AM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-15-24 06:45AM
09:21AM Loading…
Feb-06-24 09:21AM
Jan-29-24 04:53AM
Jan-26-24 02:22AM
Jan-25-24 03:37AM
Jan-24-24 05:37AM
Jan-23-24 05:23AM
Jan-22-24 04:12AM
Jan-16-24 02:39AM
Jan-11-24 04:30AM
Jan-10-24 07:44AM
Dec-30-23 08:49AM
Dec-06-23 11:55AM
Nov-22-23 06:45AM
Nov-08-23 04:57PM
Nov-07-23 09:36AM
09:30AM
06:45AM
06:32AM
Oct-31-23 10:01AM
Oct-24-23 06:45AM
Oct-12-23 08:00AM
Oct-05-23 02:30AM
Sep-06-23 08:30AM
Aug-28-23 09:07AM
Aug-25-23 09:42AM
Aug-24-23 06:45AM
Aug-11-23 09:55AM
Aug-09-23 12:11AM
Aug-08-23 12:33PM
10:32AM
10:00AM
09:51AM
08:05AM
06:45AM
Jul-31-23 11:58PM
Jul-25-23 06:45AM
Jul-11-23 08:00AM
Jun-28-23 07:00AM
Jun-16-23 08:21AM
Jun-12-23 07:11AM
May-25-23 08:01AM
May-22-23 08:11AM
May-21-23 07:45AM
May-15-23 08:30AM
May-10-23 01:46AM
May-09-23 08:05AM
06:45AM
May-08-23 06:45AM
May-05-23 02:24PM
08:31AM
Apr-28-23 02:34AM
Apr-25-23 04:05PM
Apr-16-23 09:15AM
Apr-12-23 08:32AM
Apr-06-23 12:04PM
Mar-31-23 07:05AM
05:19AM
Mar-29-23 07:33AM
Mar-23-23 06:40AM
Mar-09-23 09:19AM
Mar-02-23 03:18PM
05:19AM
Mar-01-23 02:26AM
Feb-28-23 12:59PM
10:43AM
09:52AM
09:16AM
08:17AM
08:05AM
06:45AM
Olaplex Holdings, Inc. is a science-enabled, technology-driven beauty company, focused on delivering its patent-protected hair care products to professional hair salons, retailers, and everyday consumers. The brand OLAPLEX is a patent-protected, proven, and potent haircare technology system that restores all hair types to its healthiest state possible. OLAPLEX created the Bond Building category which protects, strengthens, and rebuilds broken bonds in the hair during and after hair services. The company was founded in 2014 and is headquartered in Santa Barbara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Belhumeur Kristi ASenior VP of AccountingMay 03 '24Sale1.6842,48071,366294,553May 07 04:18 PM
BILBREY JOHN PDirectorSep 15 '23Buy2.298,10018,54958,100Sep 18 05:16 PM
BILBREY JOHN PDirectorAug 15 '23Buy2.6343,500114,40550,000Aug 15 04:10 PM
BILBREY JOHN PDirectorAug 14 '23Buy2.656,50017,2256,500Aug 15 04:10 PM